Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith G Oldroyd

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
JACC. Cardiovascular Interventions|February 25, 2017
Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete DataColin Berry, Margaret McEntegart, Mark C Petrie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 28, 2015
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX studyStuart Watkins, Keith G Oldroyd, Istvan Preda, et al.
European Heart Journal|August 30, 2014
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention SocietyMamas A Mamas, Simon G Anderson, Peter D O'Kane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)Helen C Routledge, Thierry Lefèvre, Antonio Colombo, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome studyDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Journal of Interventional Cardiology|April 21, 2021
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical OutcomesIan B A Menown, Mamas A Mamas, James M Cotton, et al.
Circulation. Cardiovascular Interventions|October 19, 2017
Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow ReserveTakeshi Nishi, Nils P Johnson, Bernard De Bruyne, et al.
European Heart Journal|August 19, 2009
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary interventionClaire E Hastie, Sandosh Padmanabhan, Rachel Slack, et al.
Journal of the American College of Cardiology|June 29, 2010
Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluationPim A L Tonino, William F Fearon, Bernard De Bruyne, et al.
Journal of Public Health (Oxford, England)|March 4, 2008
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in ScotlandDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
JACC. Cardiovascular Interventions|February 25, 2017
Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete DataColin Berry, Margaret McEntegart, Mark C Petrie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 28, 2015
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX studyStuart Watkins, Keith G Oldroyd, Istvan Preda, et al.
European Heart Journal|August 30, 2014
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention SocietyMamas A Mamas, Simon G Anderson, Peter D O'Kane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)Helen C Routledge, Thierry Lefèvre, Antonio Colombo, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome studyDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Journal of Interventional Cardiology|April 21, 2021
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical OutcomesIan B A Menown, Mamas A Mamas, James M Cotton, et al.
Circulation. Cardiovascular Interventions|October 19, 2017
Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow ReserveTakeshi Nishi, Nils P Johnson, Bernard De Bruyne, et al.
European Heart Journal|August 19, 2009
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary interventionClaire E Hastie, Sandosh Padmanabhan, Rachel Slack, et al.
Journal of the American College of Cardiology|June 29, 2010
Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluationPim A L Tonino, William F Fearon, Bernard De Bruyne, et al.
Journal of Public Health (Oxford, England)|March 4, 2008
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in ScotlandDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Pageof 22